These findings indicated that GCV administration in the IL18-GCV group induced the following phenomenon: augmentation of immune cell infiltration (9), collapse of tumor mass by apoptosis (12), processing of tumor antigens from the apoptotic tumor cells by recruited APCs that lead to antigen spreading (26), and induction of tumor-specific CTL (7,27). This evidence concerns the gene IL18 and neoplasm.